Pfizer (NYSE:PFE): BMO Capital finds current weaknesses with the shares to present a buying opportunity, and is expecting a stronger performance in 2H13 based on several potentially positive catalysts.
Cummins (NYSE:CMI): BMO Capital finds the decline following lower than expected adjusted EPS to be an overreaction, an that the company will benefit from stronger truck engine sales and new products, as well as a rebound in construction equipment purchases. It keeps an Outperform rating on the shares.
Williams-Sonoma (NYSE:WSM): Morgan Stanley thinks that international expansion growth has been underappreciated, and has accordingly raised its estimates based on increased confidence. The company can add 3-6 percent of upside to its revised numbers over the next several years according to the firm, which rates the shares at Overweight with a $60 price target.
Investing Insights: Do These Factors Support All-Time Highs In Johnson & Johnson?